EZZ Stock Overview
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
EZZ Life Science Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$4.35 |
| 52 Week High | AU$4.97 |
| 52 Week Low | AU$0.45 |
| Beta | 0.47 |
| 11 Month Change | 39.42% |
| 3 Month Change | 85.11% |
| 1 Year Change | 549.25% |
| 33 Year Change | 761.39% |
| 5 Year Change | n/a |
| Change since IPO | 275.00% |
Recent News & Updates
Recent updates
EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story
Aug 28
EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Jun 05There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise
Apr 02Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching
Feb 09EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings
Oct 18EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations
Mar 06Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)
Nov 22Shareholder Returns
| EZZ | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | 5.6% | 2.6% | 0.6% |
| 1Y | 549.3% | 29.8% | 19.9% |
Return vs Industry: EZZ exceeded the Australian Life Sciences industry which returned 29.8% over the past year.
Return vs Market: EZZ exceeded the Australian Market which returned 19.9% over the past year.
Price Volatility
| EZZ volatility | |
|---|---|
| EZZ Average Weekly Movement | 15.1% |
| Life Sciences Industry Average Movement | 11.5% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: EZZ's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: EZZ's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Qizhou Qin | ezzlife.com.au |
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand.
EZZ Life Science Holdings Limited Fundamentals Summary
| EZZ fundamental statistics | |
|---|---|
| Market cap | AU$193.24m |
| Earnings (TTM) | AU$6.96m |
| Revenue (TTM) | AU$66.44m |
27.7x
P/E Ratio2.9x
P/S RatioIs EZZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EZZ income statement (TTM) | |
|---|---|
| Revenue | AU$66.44m |
| Cost of Revenue | AU$15.50m |
| Gross Profit | AU$50.95m |
| Other Expenses | AU$43.98m |
| Earnings | AU$6.96m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 76.68% |
| Net Profit Margin | 10.48% |
| Debt/Equity Ratio | 0% |
How did EZZ perform over the long term?
See historical performance and comparison